This inventor holds 1 USPTO granted patent. Top assignees: Kansai Medical University, Zeria Pharmaceutical Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 45 Years Active: 2008
Title: Shigeo Mori: Innovator in Antibody Development
Introduction
Shigeo Mori is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Shigeo Mori holds a patent for "Antibodies specific for phosphorylation sites and screening methods using the same antibodies." This includes a polyclonal antibody that is specific for a phosphorylated linker region in Smad2 and/or Smad3. This invention is crucial for advancing research in cellular signaling and disease mechanisms.
Career Highlights
Throughout his career, Mori has worked with reputable organizations, including Zeria Pharmaceutical Co., Ltd. and Kansai Medical University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.
Collaborations
Mori has collaborated with notable colleagues such as Koichi Matsuzaki and Toshihito Seki. These partnerships have enhanced his research and expanded the impact of his innovations in the scientific community.
Conclusion
Shigeo Mori's contributions to antibody development exemplify the vital role of inventors in advancing medical science. His work continues to influence research and innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile